Institution statistics

ISTITUTO EUROPEO DI ONCOLOGIA SRL - Italy 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:600-700
Total Number of Projects:500-600
Networking Rank (Reputation):500-600
Partner Constancy:300-400
Project Leadership Index:500-600
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:500-600
Total Project Funding:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:300-400
Networking Rank (Reputation):400-500
Partner Constancy:400-500
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:900-1000
Total Project Funding:700-800
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:700-800
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding:> 1000
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:100-200
Diversity Index:500-600
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:100-200
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 67
As coordinator: 3
As participant: 54
Sole participant: 10
Coordinator / Participant Ratio: 0.06*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 13.930.695 488.125 2
2018 150.000 8.564.406 434.625 1 2
2017 0 10.989.616 2.503.100 3
2016 0 8.500.000 335.000 2
2015 0 25.593.416 1.474.204 6
2014 0 6.497.804 6.189.800 3
2013 0 4.263.618 453.174 2
2011 0 87.174.464 8.739.769 8
2010 0 18.392.711 433.097 3
2009 1.416.750 6.111.286 1.936.728 2 3
2008 50.000 36.529.858 3.577.768 1 7
2007 1.989.451 0 1.989.451 1
2006 0 26.597.800 1.272.802 3
2005 143.179 23.909.115 1.572.302 1 2
2004 0 29.778.176 1.944.694 4
2002 130.712 1.922.000 520.141 1 2
2001 2.090.018 2.154.040 678.738 2 2
2000 1.020.273 0 601.982 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE13
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE12
EUROPEAN MOLECULAR BIOLOGY LABORATORY11
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III9
INSTITUT CURIE7
KAROLINSKA INSTITUTE7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS6
INSTITUT PASTEUR6
LUNDS UNIVERSITET6
UNIVERSITY COLLEGE LONDON6
UNIVERSITY OF COPENHAGEN6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V5
FUNDACIO CENTRE DE REGULACIO GENOMICA5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
KATHOLIEKE UNIVERSITEIT LEUVEN5
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV5
PHILIPS ELECTRONICS NEDERLAND B V5
STICHTING KATHOLIEKE UNIVERSITEIT5
THE UNIVERSITY OF EDINBURGH5
UNIVERSITAET DES SAARLANDES5
ACADEMISCH ZIEKENHUIS GRONINGEN4
DEUTSCHES KREBSFORSCHUNGSZENTRUM4
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH4
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE4
INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET EN AUTOMATIQUE4
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS4
UNIVERSITA DEGLI STUDI DI MILANO4
UPPSALA UNIVERSITET4
WEIZMANN INSTITUTE OF SCIENCE4
A PERSIDIS & SIA OE3
DANISH CANCER SOCIETY3
DIAGENODE3
ECANCERMEDICALSCIENCE3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
EUROPEAN CANCER ORGANISATION3
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL3
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA3
GENOME RESEARCH3
GOETEBORGS UNIVERSITET3
GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
INSTITUT GUSTAVE ROUSSY3
KING'S COLLEGE LONDON3
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW3
MASARYKOVA UNIVERZITA3
MEDICAL RESEARCH COUNCIL3
SECONDA UNIVERSITA DEGLI STUDI DI NAPOLI3
SIVECO ROMANIA3
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS3
SWISS INSTITUTE OF BIOINFORMATICS3
THE BABRAHAM INSTITUTE3
THE HEBREW UNIVERSITY OF JERUSALEM3
UNIVERSIDAD POLITECNICA DE MADRID3
UNIVERSITAET LEIPZIG3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITE DE GENEVE3
AARHUS UNIVERSITETSHOSPITAL SKEJBY2
ACADEMISCH ZIEKENHUIS LEIDEN2
AGENDIA BV2
ASSOCIATION HOSPITALIERE DE BRUXELLES CENTRE HOSPITALIER UNIVERSITAIRE BORDET ASSOCIATION DE DROIT PUBLIC ASBL2
CELLZOME2
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN2
CONSIGLIO NAZIONALE DELLE RICERCHE2
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA2
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
GEIE ERCIM2
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI2
HEALTHGRID2
HOKKAIDO UNIVERSITY2
HUMANITAS UNIVERSITY2
INSTITUT CATALA D'ONCOLOGIA2
INSTITUT JULES BORDET2
INSTITUTE OF MICROBIOLOGY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC2
INSTYTUT CHEMII BIOORGANICZNEJ PAN2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
KOBENHAVNS UNIVERSITET2
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN2
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN2
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
OSLO UNIVERSITETSSYKEHUS HF2
OXFORD NANOPORE TECHNOLOGIES2
POLITECNICO DI MILANO2
RUPRECHT KARLS UNIVERSITAET HEIDELBERG2
TECHNISCHE UNIVERSITAET DRESDEN2
TECHNISCHE UNIVERSITEIT DELFT2
THE NETHERLANDS CANCER INSTITUTE / ANTONI VAN LEEUWENHOEK HOSPITAL2
THE UNIVERSITY OF MANCHESTER2
UNIVERSIDAD DE MALAGA2
UNIVERSITA DEGLI STUDI DI PISA2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
Constancy:

Total number of partners:716

Partner loyalty:
Frequent Partner: (> 2 projects): 271
Rare Partner: 445

Frequent / Rare Partner Ratio: 0.61

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES38
RTD HORIZONTAL TOPICS25
SOCIAL AND ECONOMIC CONCERNS11
PROTECTING MAN AND HIS ENVIRON5
INDUSTRY AND TECHNOLOGY3
AGRICULTURE AND MARINE RESOURC1
ENERGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-04-01AuTonomous intraLuminAl Surgery ATLASparticipant3.944.50921
2019-01-01European Proteomics Infrastructure Consortium providing Access EPIC-XSparticipant9.986.18618
2018-09-01Chromatin architecture and Design ChromDesignparticipant3.408.20717
2018-02-01EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts EDIReXparticipant5.156.19919
2018-01-01Immuno-targeting of human AML quiescent cells by a novel phage display approach. ITHACAcoordinator150.0001
2017-11-01Dissecting the Function of Multiple Polycomb Group Complexes in Establishing Transcriptional Identity DissectPcGparticipant2.000.0001
2017-11-01Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back BOUNCEparticipant4.999.4109
2017-01-01SMart weArable Robotic Teleoperated Surgery SMARTsurgparticipant3.990.20611
2016-11-01The inflammatory gene expression program in macrophages: An integrative approach for the systematic characterization of transcriptional co-regulators MEDICIparticipant2.500.0002
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2015-12-01Training Network for the Immunotherapy of Cancer IMMUTRAINparticipant3.627.52510
2015-10-01Leading Innovative measures to reach gender Balance in Research Activities LIBRAparticipant2.291.64111
2015-09-01Female cancer prediction using cervical omics to individualise screening and prevention FORECEEparticipant7.994.74614
2015-05-01Integrating Epidemiology and Experimental Biology to Improve Risk Assessment of Exposure to Mixtures of Endocrine Disruptive Compounds EDC-MixRiskparticipant6.223.33012
2015-02-01iManageCancer - Empowering patients and strengthening self-management in cancer diseases iManageCancerparticipant4.856.17410
2015-01-01European Consortium for Communicating Stem Cell Research EuroStemCellparticipant600.00031
2014-09-01Modeling Disease through Cell Reprogramming: a Translational Approach to the Pathogenesis of Syndromes Caused by Symmetrical Gene Dosage Imbalances DISEASEAVATARSparticipant1.997.8042
2014-07-01Immune mechanisms that control the homeostasis of the gut and that are deregulated in intestinal pathologies cancer HOMEOGUTparticipant2.000.0002
2014-07-01Inside mechanisms sustaining cancer stem cells INMECparticipant2.500.0001
2013-11-01Universal Flu Vaccine UNIVACFLUparticipant4.116.7018
2013-07-017kDa TSLP as a novel type of anti-inflammatory agent to re-establish immune homeostasis 7TREIMHOparticipant146.9172
2011-12-01Developing a global understanding of the PRC and NuRD complexes in stem cell differentiation, in health and disease 4DCELLFATEparticipant11.982.40313
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-09-01Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe HPV-AHEADparticipant2.999.94611
2011-07-01"Connecting the activities of c-Myc in genome regulation, cellular growth control and oncogenesis" MYCNEXTparticipant2.494.0001
2011-06-01The genomic blueprint of macrophages: dissecting players and mechanisms through an integrative approach NORMparticipant2.436.2001
2011-02-01From data sharing and integration via VPH models to personalised medicine p-medicineparticipant13.329.89819
2011-01-01Systems biology of liver cancer: an integrative genomic-epigenomic approach MODHEPparticipant11.936.89918
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2010-12-01Euro-BioImaging - Research infrastructure for imaging technologies in biological and biomedical sciences Euro-BioImagingparticipant5.198.24442
2010-07-01AnThocyanin and polyphenol bioactives for Health Enhancement through Nutritional Advancement ATHENAparticipant2.996.22613
2010-06-01Systems Biology of Mitosis MitoSysparticipant10.198.24114
2009-05-01Establishing an efficient network for cancer communication in Europe EUROCANCERCOMScoordinator1.252.54218
2009-04-01Structural and functional characterization of the RZZ Complex RZZcoordinator164.2081
2009-03-16A coordinated and structured international post-doctoral program to foster trans-national mobility and independent career of scientists in biomedicine SIPODparticipant1.011.9364
2009-03-01Molecular bases of kinetochore-microtubule attachment and their implications for cell cycle control KINCONparticipant2.500.0002
2009-02-01Early and late health risks to normal/healthy tissues from the use of existing and emerging techniques for radiation therapy ALLEGROparticipant2.599.35013
2008-12-01Genomic determinants of inflammation: from physical measurements to system perturbation and mathematical modeling MODEL-INparticipant2.926.30511
2008-10-01Health-promoting cross-talk between intestinal microbiota and humans CROSS-TALKparticipant3.039.34410
2008-07-01Mucosal dendritic cells in intestinal homeostasis and bacteria-related diseases DENDROWORLDparticipant1.195.6801
2008-06-01Dynamic imaging the mucosal immune system GUTIMMUNOIMAGINGcoordinator50.0001
2008-03-01Mucosal protease and their inhibitors in inflammatory bowel disease: From etiopathogenetic insight to innovative therapy IBDASEparticipant2.973.55010
2008-03-01European consortium for systematic stem cell biology EUROSYSTEMparticipant12.000.00025
2008-01-01Metagenomics of the human intestinal tract METAHITparticipant11.400.00016
2008-01-01Genomic instability in cancer and precancer GENICAparticipant2.994.97911
2007-01-01Targeting transcriptional mechanisms in chronic inflammation-associated diseases TRANS-TARcoordinator1.989.4511
2006-10-01Cancer stem cells and asymmetric cell division ONCASYMparticipant2.823.8008
2006-02-01Advancing Clinico-Genomic Trials on Cancer: Open Grid Services for Improving Medical Knowledge Discovery ACGTparticipant11.887.00028
2006-02-01Advancing Clinico-Genomic Trials on Cancer: Open Grid Services for Improving Medical Knowledge Discovery ACGTparticipant11.887.00024
2005-11-01Epigenetic treatment of neoplastic disease EPITRONparticipant10.904.47414

overview shows latest 50 from 67 projects (2000-01-01 - 2019-12-31)
A full list of projects can be found here:

Alias institution names:
  • ISTITUTO EUROPEO DI ONCOLOGIA

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum